Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue 5, 2012, Pages 452-459

  Messenger, K M ^a   Papich, M G ^a   Blikslager, A T ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TISSUE LEVEL; EXPERIMENTAL PIG; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTERSTITIAL FLUID; INTRAVENOUS CATHETER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA HALF LIFE; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN BINDING; ULTRAFILTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIA; CIPROFLOXACIN; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, SUBCUTANEOUS; MICROBIAL SENSITIVITY TESTS; SWINE;

SUIDAE;

EID: 84866152144     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2011.01338.x     Document Type: Article

References (35)

1. Abo-El-Sooud, K. & Goudah, A. (2009) Influence of Pasteurella multocida infection on the pharmacokinetics behavior of marbofloxacin after intravenous and intramuscular administration in rabbits. Journal of Veterinary Pharmacology and Therapeutics, 33, 63-68.
2. AliAbadi, F.S. & Lees, P. (2000) Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimization. International Journal of Antimicrobial Agents, 14, 307-313.
3. Anadón, A., Martínez-Larrañaga, M.R., Díaz, M.J., Fernández-Cruz, M.L., Martínez, M.A., Frejo, M.T., Martínez, M., Iturbe, J. & Tafur, M. (1999) Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. American Journal of Veterinary Research, 60, 1377-1382.
4. Ashby, J., Piddock, L.J.V. & Wise, R. (1985) An investigation of the hydrophobicity of the quinolones. Journal of Antimicrobial Chemotherapy, 16, 805-808.
5. Bermingham, E.C. & Papich, M.G. (2002) Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. American Journal of Veterinary Research, 63, 1012-1017.
6. Bermingham, E.C., Papich, M.G. & Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706-709.
7. Bidgood, T. & Papich, M.G. (2002) Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs. American Journal of Veterinary Research, 63, 1622-1628.
8. Bidgood, T. & Papich, M.G. (2005) Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 329-341.
9. Bimazubute, M., Cambier, C., Baert, K., Vanbelle, S., Chiap, P., Albert, A., Delporte, J.P. & Gustin, P. (2010) Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. Journal of Veterinary Pharmacology and Therapeutics, 33, 183-188.
10. Bregante, M.A., DeJong, A., Aramayona, J.J., Garcia, M.A., Solans, C. & Rueda, S. (2000) Protein binding of fluoroquinolones applied to livestock and companion animals. Journal of Veterinary Pharmacology and Therapeutics, 23 (Suppl. 1), B16.
11. Cars, O. (1991) Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scandinavian Journal of Infectious Diseases, 74, 23-33.
12. Cars, O. & Ogren, S. (1985) Antibiotic tissue concentrations: methodological aspects and interpretation of results. Scandinavian Journal of Infectious Diseases, 44, 7-15.
13. Clinical and Laboratory Standards Institute (CLSI). (2011) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 4th edn. CLSI document M31-A4. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898 USA. Fourth Edition is not due for publication until Fall, 2011. New swine breakpoints are not listed in previous editions.
14. Davis, J.L., Salmon, J.H. & Papich, M.G. (2005) Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 425-431.
15. Davis, J.L., Salmon, J.H. & Papich, M.G. (2006) Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. American Journal of Veterinary Research, 67, 310-316.
16. Davis, J.L., Foster, D.M. & Papich, M.G. (2007) Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. Journal of Veterinary Pharmacology and Therapeutics, 30, 564-571.
17. Grobbel, M., Lübke-Becker, A., Wieler, L.H., Froyman, R., Friederichs, S. & Filios, S. (2007) Comparative quantification of the in vitro activity of veterinary fluoroquinolones. Veterinary Microbiology, 124, 73-81.
18. Linhares, M.C. & Kissinger, P.T. (1993) Pharmacokinetic monitoring in subcutaneous tissue using in vivo capillary ultrafiltration probes. Pharmaceutical Research, 10, 598-602.
19. Liu, P., Müller, M. & Derendorf, H. (2002) Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents, 19, 285-290.
20. Mouton, J.W., Dudley, M.N., Cars, O., Derendorf, H. & Drusano, G.L. (2005) Standardization of pharmacokinetic / pharmacodynamic (PK / PD) terminology for anti-infective drugs: an update. Journal of Antimicrobial Chemotherapy, 55, 601-607.
21. Mouton, J.W., Theuretzbacher, U., Craig, W.A., Tulkens, P.M., Derendorf, H. & Cars, O. (2008) Tissue concentrations: do we ever learn. Journal of Antimicrobial Chemotherapy, 61, 235-237.
22. Nielsen, P. & Gyrd-Hansen, N. (1997) Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacology and Toxicology, 80, 246-250.
23. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L. & Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrobial Agents and Chemotherapy, 35, 1947-1952.
24. Nouws, J.F.M., Mevius, D.J., Vree, T.B., Baars, A.M. & Laurensen, J. (1988) Pharmacokinetics, renal clearance, and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Veterinary Quarterly, 10, 156-163.
25. Papich, M.G. & Riviere, J.E. (2009) Chapter 38. Fluoroquinolone antimicrobial drugs. In Veterinary Pharmacology and Therapeutics, 9th edn. Eds Riviere, J.E. & Papich, M.G., pp. 983-1011. Wiley-Blackwell Publishing, Ames, IA, USA.
26. Post, L.O., Farrell, D.E., Cope, C.V., Baker, J.D. & Myers, M.J. (2003) The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. Journal of Pharmacology and Experimental Therapeutics, 304, 889-895.
27. Rao, G.S., Ramesh, S., Ahmad, A.H., Tripathi, H.C., Sharma, L.D. & Malik, J.K. (2000) Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats. Journal of Veterinary Pharmacology and Therapeutics, 23, 365-372.
28. Stegemann, M.R., Sherington, J. & Blanchflower, S. (2006) Pharmacokinetics and pharmacodynamics of cefovecin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 29, 501-511.
29. Toutain, P.L., del Castillo, J.R. & Bousquet-Mélou, A. (2002) The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105-114.
30. United States Pharmacopeia (USP-NF). (2009) USP32-NF27. General Chapter on Validation of Compendial Procedures 1225. USP, Rockville, MD, USA.
31. Villa, R., Prandini, E., Caloni, F. & Carli, S. (1997) Serum protein binding of some sulfonamides, quinolones, and fluoroquinolones in farm animals and domestic animals. Journal of Veterinary Pharmacology and Therapeutics, 20, 34-35.
32. Wiuff, C., Lykkesfeldt, J., Aarestrup, F.M. & Svendsen, O. (2002) Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. Journal of Veterinary Pharmacology and Therapeutics, 25, 335-342.
33. Wright, D.H., Brown, G.H., Peterson, M.L. & Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683.
34. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
35. Zeng, Z.I. & Fung, K.F. (1997) Effects of experimentally induced Escherichia coli infection on the pharmacokinetics of enrofloxacin in pigs. Journal of Veterinary Pharmacology and Therapeutics, 20, 39-40.